Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges about an upcoming institutional investor meeting scheduled for Thursday, August 14, 2025. The meeting will be held in-person with Axis Mutual Fund. The company clarified that no unpublished price sensitive information (UPSI) will be discussed, and only publicly available documents will be referenced. The intimation is filed in compliance with SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The schedule is subject to change due to unforeseen developments.
This is a routine compliance disclosure and is unlikely to have any material impact on the stock price. Investors should monitor for any follow-up announcements or outcomes from the meeting that could provide insight into institutional investor sentiment toward the stock.